207 related articles for article (PubMed ID: 32760270)
1. Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases.
Shetty T; Corson TW
Front Pharmacol; 2020; 11():1015. PubMed ID: 32760270
[No Abstract] [Full Text] [Related]
2. Ferrochelatase is a therapeutic target for ocular neovascularization.
Basavarajappa HD; Sulaiman RS; Qi X; Shetty T; Sheik Pran Babu S; Sishtla KL; Lee B; Quigley J; Alkhairy S; Briggs CM; Gupta K; Tang B; Shadmand M; Grant MB; Boulton ME; Seo SY; Corson TW
EMBO Mol Med; 2017 Jun; 9(6):786-801. PubMed ID: 28377496
[TBL] [Abstract][Full Text] [Related]
3. Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.
Patel D; Alhawaj R; Kelly MR; Accarino JJ; Lakhkar A; Gupte SA; Sun D; Wolin MS
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1439-47. PubMed ID: 27037373
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
5. Cavin-2 regulates the activity and stability of endothelial nitric-oxide synthase (eNOS) in angiogenesis.
Boopathy GTK; Kulkarni M; Ho SY; Boey A; Chua EWM; Barathi VA; Carney TJ; Wang X; Hong W
J Biol Chem; 2017 Oct; 292(43):17760-17776. PubMed ID: 28912276
[TBL] [Abstract][Full Text] [Related]
6. Ferrochelatase regulates retinal neovascularization.
Pran Babu SPS; White D; Corson TW
FASEB J; 2020 Sep; 34(9):12419-12435. PubMed ID: 32716567
[TBL] [Abstract][Full Text] [Related]
7. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
8. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Andreoli CM; Miller JW
Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
[TBL] [Abstract][Full Text] [Related]
9. The heme synthesis defect of mutants impaired in mitochondrial iron-sulfur protein biogenesis is caused by reversible inhibition of ferrochelatase.
Lange H; Mühlenhoff U; Denzel M; Kispal G; Lill R
J Biol Chem; 2004 Jul; 279(28):29101-8. PubMed ID: 15128732
[TBL] [Abstract][Full Text] [Related]
10. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes.
Awata T; Neda T; Iizuka H; Kurihara S; Ohkubo T; Takata N; Osaki M; Watanabe M; Nakashima Y; Sawa T; Inukai K; Inoue I; Shibuya M; Mori K; Yoneya S; Katayama S
Diabetes Care; 2004 Sep; 27(9):2184-90. PubMed ID: 15333482
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling.
Zhang B; Alruwaili N; Kandhi S; Deng W; Huang A; Wolin MS; Sun D
PLoS One; 2018; 13(7):e0200307. PubMed ID: 29985945
[TBL] [Abstract][Full Text] [Related]
12. Dissecting regulation mechanism of the FMN to heme interdomain electron transfer in nitric oxide synthases.
Feng C; Chen L; Li W; Elmore BO; Fan W; Sun X
J Inorg Biochem; 2014 Jan; 130():130-40. PubMed ID: 24084585
[TBL] [Abstract][Full Text] [Related]
13. IL-17A Enhances Retinal Neovascularization.
Taylor BE; Lee CA; Zapadka TE; Zhou AY; Barber KG; Taylor ZRR; Howell SJ; Taylor PR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675261
[TBL] [Abstract][Full Text] [Related]
14. Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction.
Shetty T; Sishtla K; Park B; Repass MJ; Corson TW
iScience; 2020 Aug; 23(8):101391. PubMed ID: 32755804
[TBL] [Abstract][Full Text] [Related]
15. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.
Shi L; Zhao M; Abbey CA; Tsai SH; Xie W; Pham D; Chapman S; Bayless KJ; Hein TW; Rosa RH; Ko ML; Kuo L; Ko GY
J Am Heart Assoc; 2019 Nov; 8(22):e013673. PubMed ID: 31698979
[TBL] [Abstract][Full Text] [Related]
16. Electron transfer, oxygen binding, and nitric oxide feedback inhibition in endothelial nitric-oxide synthase.
Abu-Soud HM; Ichimori K; Presta A; Stuehr DJ
J Biol Chem; 2000 Jun; 275(23):17349-57. PubMed ID: 10749853
[TBL] [Abstract][Full Text] [Related]
17. Real-life anti-vascular endothelial growth factor treatment for age-related macular degeneration and diabetic macular edema in an Italian tertiary referral hospital.
Battaglia Parodi M; Romano F; Arrigo A; Sacchi R; Scanzi G; Ferri C; Bandello F
Eur J Ophthalmol; 2020 Nov; 30(6):1461-1466. PubMed ID: 31617403
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration.
Frank RN; Amin RH; Puklin JE
Am J Ophthalmol; 1999 Jun; 127(6):694-709. PubMed ID: 10372880
[TBL] [Abstract][Full Text] [Related]
19. Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Tsao YC; Chen TY; Wang LA; Lee CC; Lee WA; Hsu SM; Lai CC; Shao SC; Hung JH; Lai EC
BioDrugs; 2023 Nov; 37(6):843-854. PubMed ID: 37676536
[TBL] [Abstract][Full Text] [Related]
20. Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration.
Huber AL; Angermann R; Nowosielski Y; Seifarth C; Kralinger MT; Zehetner C
J Ophthalmol; 2021; 2021():7058505. PubMed ID: 34956670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
